June 26, 2015

As of June 16, 2015, it has been announced that a collaboration agreement for services and research has been reached between CellResearch Corporation Pte Ltd, a stem cell technology company, and the University of Colorado School of Medicine and ClinImmune Labs, two organizations that are a part of the University of Colorado Anschutz Medical Campus in Aurora, CO. CariCord is part of this medical campus as a US FDA-licensed, cGMP stem cell and umbilical cord blood bank.

The University of Colorado School of Medicine, in addition to having an umbilical cord blood banking service that serves mothers after their pregnancy stages, is one of the top public urban research universities in the United States. It currently has more than 14,000 students on its campus in Downtown Denver, as well as more than 3,000 students in its research and advanced health care programs at the Anschutz Medical Campus in Aurora. Many of these students can answer the question, “What is stem cell research?” and talk to expecting mothers about umbilical cord blood banking during their stages of pregnancy.

CellResearch Corporation Pte Ltd (CRC) was founded in 2002 by a group of clinician scientists and investors in Singapore. CRC is a pioneer and global leader in the field of stem cell research and cord lining stem cells for stem cell regenerative medicine and therapy. CRC is both an inventor and market leader in this sphere. It’s main business purposes are the banking of cord lining stem cells, developing cosmeceuticals in the form of their product, and advanced wound care. Cord blood can be used for anemia treatment in many cases.

The first collaboration will be focused on the development of CRC’s proprietary and patented cord lining mesenchymal stem cells for the treatment of diabetic wounds. Umbilical cord blood banking after a mother’s pregnancy stages can have many uses, including anemia treatment. Dr. Brian Freed, who serves as the Executive Director of ClinImmune Labs and a Professor at the Division of Allergy and Clinical Immunology of the University of Colorado School of Medicine will head the project. He is a leading expert in the field of stem cell therapy, with more than 30 years of experience and 80 publications on the topic.

FaceBook  Twitter